RVRC Revium Rx.
Revium Rx. (RVRC) news
Revium Rx. is a public biotech or pharmaceutical company listed on OTC under the ticker RVRC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Revium Rx. news
We have not published a story on Revium Rx. yet. When there is news, it will appear here.
Revium Rx. annual financials
| Line | FY2025 |
|---|---|
| Net income (loss) | -$13.4 million |
| Cash and equivalents | $1.7 million |
Questions about Revium Rx.
What is the ticker symbol of Revium Rx.?
Revium Rx. trades under the ticker RVRC on OTC.
Where is Revium Rx. listed?
Revium Rx. is listed on OTC.
Which country or territory is Revium Rx. listed under?
Our directory records Revium Rx. under United States.
Does aibio.space cover Revium Rx.?
aibio.space lists Revium Rx. among 2,820 public biotech companies and publishes its news here as stories appear.
Is Revium Rx. profitable?
Revium Rx. reported a net loss of $13.4 million for the fiscal year ended Dec 31, 2025, per its annual report to the SEC.
How much cash does Revium Rx. have?
$842,000 in cash at Jun 30, 2026, per its 10-Q.
Investor discussion: Revium Rx.
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- Revium Rx.
- Ticker
- RVRC
- Listing
- OTC
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio